Mike has a wide breadth of experience in drug development from Phase I to commercialization, process development/scalue, tech-transfer, mergers, integrations, due diligence, risk, and financial planning. He previously held various leadership roles at Mallinckrodt Pharmaceuticals, Allergan, Endo Pharmaceuticals, and Teva. Mike holds a BS in Chemical Engineering from Drexel University.